Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added related-topic links for Multiple myeloma and MedlinePlus Genetics to provide background context. These changes do not alter the study details or how a user would interact with the page.
    Difference
    0.0%
    Check dated 2026-01-21T06:50:19.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added. Related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' as well as 'Revision: v3.3.3' were removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:27:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now lists related topics: Multiple myeloma and MedlinePlus Genetics, linking to related resources. This is a navigational enhancement and does not modify the study details or results.
    Difference
    0.0%
    Check dated 2026-01-07T02:18:18.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related topics from the page. This reduces cross-linking to disease-specific topics and genetics resources on the study record.
    Difference
    0.0%
    Check dated 2025-12-31T00:57:59.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The Study Details page now lists hundreds of new locations across multiple regions and adds related topics such as MedlinePlus Genetics. Recruitment-related information and contact details were updated.
    Difference
    7%
    Check dated 2025-12-23T21:55:54.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    MagnetisMM-7 (NCT05317416) recruitment status updated to Active, not recruiting as of 2025-12-15, replacing the prior Recruiting status. Enrollment is not open at listed sites.
    Difference
    0.2%
    Check dated 2025-12-16T21:20:44.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.